Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Western Blotting Market Growth & Trends

The global western blotting market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Western Blotting Market Report Highlights

• The consumables segment dominated the market with a share of 68.1% in 2023. The consumables segment witnessed a significant demand based on the augmented sensitivity, efficiency, and specificity of the western blotting method.
• The disease diagnostics segment dominated the western blotting market with a revenue share of 60.4% in 2023. The growing incidences of Factor V, Herplex Symptoms Virus (HSV), Hepatitis B Virus (HBV), and Lyme sickness, incidences of chronic diseases such as cancers, and autoimmune disorders account for segment growth.
• The pharmaceutical and biotechnology companies segment dominated the market with a revenue share of 32.0% in 2023. The growing focus on targeted treatment, personalized medicine, and increasing investment in drug discovery contribute to the segment growth.
• North America western blotting market dominated the global market with a revenue share of 41.8% in 2023. The presence of manufacturing companies in the region, growing investment in proteomics studies, and a growing awareness of customized medicine encourage growth.

Please note The report will be delivered in 2-3 business days upon order notification.